Clayton RN - Search Results

1

Evidence for the use of igf-I as a predictor of mortality in acromegaly is lacking.

Ayuk J, Sheppard MC, Clayton RN, Bates AS, Stewart PM. Ayuk J, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 2004 Nov;89(11):5867-8; author reply 5868. doi: 10.1210/jc.2004-1475. J Clin Endocrinol Metab. 2004. PMID: 15531556 No abstract available.

2

A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk.

Sherlock M, Reulen RC, Aragon-Alonso A, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM. Sherlock M, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 2014 Feb;99(2):478-85. doi: 10.1210/jc.2013-2450. Epub 2013 Nov 15. J Clin Endocrinol Metab. 2014. PMID: 24243636

3

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.

Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS. Ayuk J, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 2004 Apr;89(4):1613-7. doi: 10.1210/jc.2003-031584. J Clin Endocrinol Metab. 2004. PMID: 15070920

4

Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.

Sherlock M, Fernandez-Rodriguez E, Alonso AA, Reulen RC, Ayuk J, Clayton RN, Holder G, Sheppard MC, Bates A, Stewart PM. Sherlock M, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 2009 Apr;94(4):1255-63. doi: 10.1210/jc.2008-1420. Epub 2009 Jan 21. J Clin Endocrinol Metab. 2009. PMID: 19158203

5

Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.

Sherlock M, Aragon Alonso A, Reulen RC, Ayuk J, Clayton RN, Holder G, Sheppard MC, Bates A, Stewart PM. Sherlock M, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 2009 Jul;71(1):74-81. doi: 10.1111/j.1365-2265.2008.03461.x. Epub 2008 Oct 26. Clin Endocrinol (Oxf). 2009. PMID: 19178529

6

ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.

Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM. Sherlock M, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 2009 Nov;94(11):4216-23. doi: 10.1210/jc.2009-1097. Epub 2009 Oct 6. J Clin Endocrinol Metab. 2009. PMID: 19808848

7

Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.

Bates AS, Evans AJ, Jones P, Clayton RN. Bates AS, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 1995 Apr;42(4):417-23. doi: 10.1111/j.1365-2265.1995.tb02651.x. Clin Endocrinol (Oxf). 1995. PMID: 7750196

8

Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion.

Bates AS, Evans AJ, Jones P, Clayton RN. Bates AS, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 1995 Apr;42(4):425-30. doi: 10.1111/j.1365-2265.1995.tb02652.x. Clin Endocrinol (Oxf). 1995. PMID: 7750197

9

An audit of outcome of treatment in acromegaly.

Bates AS, Van't Hoff W, Jones JM, Clayton RN. Bates AS, et al. Among authors: clayton rn. Q J Med. 1993 May;86(5):293-9. Q J Med. 1993. PMID: 8327647

10

The effect of hypopituitarism on life expectancy.

Bates AS, Van't Hoff W, Jones PJ, Clayton RN. Bates AS, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 1996 Mar;81(3):1169-72. doi: 10.1210/jcem.81.3.8772595. J Clin Endocrinol Metab. 1996. PMID: 8772595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters